Results 171 to 180 of about 30,886 (233)

PRDM1 Is a Key Regulator of the NKT-cell Central Memory Program and Effector Function. [PDF]

Cancer Immunol Res
Tian G, Barragan GA, Yu H, Martinez-Amador C, Adaikkalavan A, Rios X, Guo L, Drabek JM, Pardias O, Xu X, Montalbano A, Zhang C, Li Y, Courtney AN, Di Pierro EJ, Metelitsa LS.   +15 more
europepmc   +1 more source

New Paradigm in NKT Cell Antigens: MCS-0208 (2-(Hydroxymethyl)phenylthio-phytoceramide) - an Aryl-Phytoceramide Compound with a Single Hydroxyl Group Stimulates NKT Cells. [PDF]

ChemMedChem, 2021
Borràs-Tudurí R, Alcaide A, Aspeslag S, Usero L, Serra C, Roura-Mir C, Elewaut D, Llebaria A.   +7 more
europepmc   +1 more source

Experimental Models of Autoimmune Hepatitis: Disease Fidelity and Translational Relevance

Liver International, Volume 46, Issue 8, August 2026.
ABSTRACT Autoimmune hepatitis (AIH) remains difficult to study mechanistically in patients because disease initiation is rarely observed directly, the relevant autoantigens differ across subsets, and clinically meaningful outcomes such as chronic inflammation, fibrosis, relapse, and treatment response evolve over time.
Laura Elisa Buitrago‐Molina, Matthias Hardtke‐Wolenski   +1 more
wiley   +1 more source

Sema3E‐plexinD1 Axis Is a Modulator of Foxp3+ Regulatory T‐Cells in House Dust Mite Model of Asthma

The FASEB Journal, Volume 40, Issue 14, 31 July 2026.
Airway epithelial‐derived Sema3E enhances both the number and proliferation of Foxp3+ regulatory T (Treg) cells in an acute model of asthma. Mechanistically, deletion of PlexinD1, the receptor for Sema3E, specifically in Foxp3+ cells was associated with a breakdown in immune regulation in this model.
Mojdeh Matloubi, Chukwunonso Onyilagha, Lianyu Shan, Sujata Basu, Andrew J. Halayko, Mohamed Almiski, Abdelilah S. Gounni   +6 more
wiley   +1 more source

Regulatory T cells induce CD4^- NKT cell anergy and suppress NKT cell cytotoxic function. [PDF]

Cancer Immunol Immunother, 2019
Ihara F, Sakurai D, Takami M, Kamata T, Kunii N, Yamasaki K, Iinuma T, Nakayama T, Motohashi S, Okamoto Y.   +9 more
europepmc   +1 more source

The Role of Gut Microbiota in Liver Regeneration After Partial Hepatectomy: New Evidence From Animal and Human Studies

The FASEB Journal, Volume 40, Issue 14, 31 July 2026.
Partial hepatectomy (PH) reshapes gut microbiota composition, resulting in the release of microbial metabolites and components, including short chain fatty acids (SCFAs)/β‐hydroxybutyric acid (BHB), bacterial DNA and extracellular vesicles (EVs), bile acids (deoxycholic acid, DCA), and aminobenzoate degradation products.
Roberto Loi, Gabriella Simbula, Andrea Caddeo, Monica Pibiri   +3 more
wiley   +1 more source

EGFR-TKIs Combined with Allogeneic CD8+ NKT Cell Immunotherapy to Treat Patients with Advanced EGFR-Mutated Lung Cancer. [PDF]

Technol Cancer Res Treat
Ye F, Yuan X, Yu W, Ma Y, Mao C, Li X, Li J, Dai C, Qian F, Li J, Fan X, Zhou Y, Dai D, Wang D, Chen D, Xia S, Zhang M.   +16 more
europepmc   +1 more source

Wavelength and Polarization Multiplexed Nonlocal Metasurface for Quantitative Phase Microscopy

Nanophotonics, Volume 15, Issue 13, 13 July 2026.
A nonlocal metasurface with wavelength and polarization multiplexed optical transfer functions is demonstrated for performing quantitative phase imaging. The metasurface uses the angular dispersion of optical routing guided mode resonances to extract phase gradient information along different directions for phase retrieval. ABSTRACT Imaging transparent
Haiwei Wang, Shikun Ma, Shaban Sulejman, Niken Priscilla, Wendy S. L. Lee, Peter Francis Mathew Elango, Lukas Wesemann, Elizabeth Hinde, Ann Roberts   +8 more
wiley   +1 more source

NK and NKT Cell-Mediated Immune Surveillance against Hematological Malignancies. [PDF]

Cancers (Basel), 2020
Shimizu K, Iyoda T, Yamasaki S, Kadowaki N, Tojo A, Fujii AS.   +5 more
europepmc   +1 more source

Letter to the Editor: EGFR-TKIs Combined with Allogeneic CD8+ NKT Cell Immunotherapy to Treat Patients with Advanced EGFR-Mutated Lung Cancer. [PDF]

Technol Cancer Res Treat
Daungsupawong H, Wiwanitkit V.
europepmc   +1 more source